Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by ChromaDex Corporation < Previous 1 2 3 Next > ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide November 07, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Third Quarter 2024 Financial Results October 31, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 October 28, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024 October 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in the 17th Annual LD Micro Main Event October 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) October 15, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in a Fireside Chat at the Lytham Partners Fall 2024 Investor Conference September 26, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Appoints Ozan Pamir as Chief Financial Officer September 20, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Expansion of Pharmaceutical-Grade Niagen® IV and Injection Offerings to Additional Leading Wellness Clinics September 10, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Celebrates 25 Years of Innovation and Pioneering NAD+ Research for Healthy Aging Solutions September 09, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024 August 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Secures U.S. Patent for the Composition of Matter of Salt Forms of NMNH (Dihydronicotinamide Mononucleotide), a Precursor to NAD+ August 19, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports Second Quarter 2024 Financial Results August 07, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference August 05, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 July 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Launches Niagen+ NAD+ Test Kit Available Exclusively to Health Care Practitioners (HCPs) July 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel July 22, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August July 16, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Join Russell 2000® Index July 01, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC Milestone Phase II Clinical Study Demonstrates Niagen®, Patented Nicotinamide Riboside (NR), Improves Functional Mobility for Individuals with Peripheral Artery Disease (PAD) June 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen® (Patented Nicotinamide Riboside Chloride or NRC) June 13, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Receives Exclusive U.S. FDA Orphan Drug Designation (ODD) and Rare Pediatric (RPD) Disease Designation for Nicotinamide Riboside Chloride (NRC) for the Treatment of Ataxia Telangiectasia (AT) June 07, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, June 11, 2024 June 04, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award May 22, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Corporation Reports First Quarter 2024 Financial Results May 08, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe® April 25, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement April 30, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 April 24, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market April 23, 2024 From ChromaDex Corporation Via Business Wire Tickers CDXC < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
